“How long does amphetamine stay detectable?” is incomplete without the specimen and reporting threshold. A detection window describes a measurement under stated conditions. It should not be presented as a fixed deadline that decides whether someone took a new dose, followed a prescription, or was impaired.
What did the controlled-dose study find?
Helland and colleagues studied 22 healthy adults. Eleven received a single oral 10 mg dexamphetamine dose; another 11 received 30 mg lisdexamphetamine, with a separate methylphenidate session. Oral fluid and urine were collected approximately every eight hours. Amphetamine cutoffs were 1.5 ng/mL in oral fluid and 50 ng/mL in urine. Urinary concentrations were creatinine-adjusted.
Model-based median last-detection times for amphetamine were 69 hours in oral fluid and 78 hours in urine after dexamphetamine, and 67 and 77 hours after lisdexamphetamine. These were estimated intersections of elimination curves with cutoffs, not exact disappearance times observed continuously. Individual estimated oral-fluid times after dexamphetamine ranged from 61 to 93 hours. Urine pH affected amphetamine concentrations. The study was small, involved single doses in healthy adults, and did not test driving impairment.
Why does the cutoff belong in the conclusion?
Imagine two otherwise identical reports using different thresholds. One can label a sample negative while the other reports a concentration. The labels can disagree without either laboratory having detected a different molecule. Before interpreting that disagreement, ask which decision rule each laboratory applied.
The same reasoning applies to a proposed detection deadline. A time estimate without its cutoff leaves out the rule defining the endpoint. It is like reporting the time a vehicle crossed a finish line without identifying where the finish line was placed.
What can a positive result establish about behavior?
The supplied 2002 Logan review addresses methamphetamine performance effects across varying exposure conditions. It is historical context, not validation of the newer study’s oral-fluid window. In addition, amphetamine measured after a prescribed prodrug and methamphetamine measured in a driving investigation must retain their separate identities.
A useful forensic report should separate the analytical statement from the behavioral opinion. “Amphetamine was measured above this reporting threshold” is an analytical proposition. “The person could not safely perform this task at an earlier time” requires evidence addressing that task and time. Moving between the two propositions needs an explicit argument.
How should a disputed testing timeline be reviewed?
Start with the original report, the identified analyte, specimen type, threshold, collection time and any concentration adjustment. State the actual question next: detection of exposure, compatibility with a stated medication history, or functional performance. Compare evidence directed to that question rather than selecting a published median as though it were an individual stopwatch.
This approach preserves useful testing information while making the limits of the proposed inference visible. It also gives another reviewer concrete assumptions to examine, rather than a general claim that the drug “lasts three days.”
Sources and evidence type
Helland A, Muller S, Spigset O, et al. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers. Journal of Analytical Toxicology. 2025;49(2):65–72. Controlled human dosing and analytical study, published online December 19, 2024. DOI: 10.1093/jat/bkae097. Full text.
Logan BK. Methamphetamine—Effects on Human Performance and Behavior. Forensic Science Review. 2002;14(1–2):133–151. Historical narrative review; supplied full text. PMID 26256490.